DBV Technologies (DBVT) Short Interest Ratio & Short Volume

Short interest is the volume of DBV Technologies shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 521,800 shares of DBVT short. Learn More on DBV Technologies' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DBVT shares currently have a short interest ratio of 7.0. Learn More on DBV Technologies's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DBV Technologies: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

DBV Technologies saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 521,800 shares, a decline of 3.2% from the previous total of 539,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to DBV Technologies: Omega Therapeutics, Inc. (24.22%), Sangamo Therapeutics, Inc. (7.10%), BioAtla, Inc. (10.81%), Molecular Partners AG (0.14%), Vigil Neuroscience, Inc. (5.93%), bluebird bio, Inc. (28.90%), aTyr Pharma, Inc. (0.50%), Outlook Therapeutics, Inc. (8.04%), Athira Pharma, Inc. (2.62%), X4 Pharmaceuticals, Inc. (7.27%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling DBVT is an investing strategy that aims to generate trading profit from DBV Technologies as its price is falling. DBVT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for DBV Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DBVT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DBVT, twice per month. The most recent reporting period available is May, 15 2024.